Home J Young Pharm. Vol 15/Issue 1/2023 Cost-Effectiveness Analysis of Atezolizumab and Bevacizumab versus Sorafenib in the Treatment of Hepatocellular Carcinoma: A Systematic Review

© Phcog.Net. 2009-2022

In co-operation with